Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Marimed (MRMD) over the last 14 years, with Q3 2025 value amounting to $9.0 million.

  • Marimed's Accumulated Expenses rose 4381.77% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 4381.77%. This contributed to the annual value of $4.4 million for FY2024, which is 2496.48% up from last year.
  • According to the latest figures from Q3 2025, Marimed's Accumulated Expenses is $9.0 million, which was up 4381.77% from $7.4 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Accumulated Expenses registered a high of $11.1 million during Q3 2021, and its lowest value of $1.7 million during Q1 2022.
  • For the 5-year period, Marimed's Accumulated Expenses averaged around $5.2 million, with its median value being $4.6 million (2024).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 25658.7% in 2021, then plummeted by 7057.17% in 2022.
  • Over the past 5 years, Marimed's Accumulated Expenses (Quarter) stood at $3.1 million in 2021, then decreased by 1.84% to $3.1 million in 2022, then increased by 14.82% to $3.5 million in 2023, then rose by 24.96% to $4.4 million in 2024, then soared by 103.52% to $9.0 million in 2025.
  • Its Accumulated Expenses stands at $9.0 million for Q3 2025, versus $7.4 million for Q2 2025 and $7.7 million for Q1 2025.